Related Experiment Video
Updated: Feb 16, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Toll-like receptor 2 activation implicated in oral squamous cell carcinoma development
Naoki Ikehata1, Masakatsu Takanashi2, Takafumi Satomi1
1Department of Oral and Maxillofacial Surgery, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo 160-0023, Japan.
Toll-like receptor 2 (TLR2) activation by bacterial components promotes oral squamous cell carcinoma (OSCC) progression. This pathway may also confer resistance to cisplatin treatment via miR-146a regulation.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Toll-like receptors (TLRs) are implicated in various cancers.
- The specific role of TLR2 in oral squamous cell carcinoma (OSCC) remains largely unknown.
- TLR2 is crucial for recognizing microbial components in the oral environment.
Purpose of the Study:
- To investigate the expression and function of TLR2 in OSCC.
- To elucidate the molecular mechanisms underlying TLR2-mediated OSCC progression.
- To determine the role of TLR2 signaling in chemoresistance in OSCC.
Main Methods:
- Quantitative analysis of TLR2 expression in OSCC tissues and cell lines.
- Stimulation of OSCC cells with bacterial and mycoplasma ligands.
- Analysis of microRNA (miRNA) expression, specifically miR-146a.
- Messenger RNA (mRNA) analysis of caspase recruitment domain-containing protein 10 (CARD10).
- Assessment of apoptosis resistance following CARD10 knockdown.
Main Results:
- TLR2 is significantly upregulated in OSCC compared to normal tissues.
- TLR2 expression in OSCC cells is activated by bacterial and mycoplasma ligands.
- TLR2 activation induces miR-146a expression and downregulates CARD10 mRNA.
- Knockdown of CARD10 confers resistance to cisplatin-induced apoptosis in OSCC cells.
Conclusions:
- TLR2 activation by microbial components promotes OSCC progression.
- The TLR2-miR-146a-CARD10 pathway contributes to acquired cisplatin resistance in OSCC.
- Targeting TLR2 signaling may offer therapeutic strategies for OSCC and chemoresistance.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

